Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002915 · ClinicalTrials.gov registry record · Phase 1
Penclomedine in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002915: Completed Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT00002915 is a Phase 1 study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002915, a Phase 1 study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of penclomedine in treating patients who have advanced solid tumors.
Interventions
- DRUG penclomedine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-12 |
| Phase | Phase 1 |
What the finished NCT00002915 record still lists
NCT00002915 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which penclomedine is the first listed.
NCT00002915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002915 about?
NCT00002915 is a clinical study titled "Penclomedine in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of penclomedine in treating patients who have advanced solid tumors.
What is the current status of trial NCT00002915?
This trial is currently completed. It is a Phase 1 study. The study started on 1996-12.
What interventions are being tested in trial NCT00002915?
The interventions under investigation include: penclomedine (DRUG).
Who is sponsoring clinical trial NCT00002915?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia